Home » Topics » Regulatory

Regulatory
RSS

Enbrel recommended by FDA advisory committee for early RA

April 17, 2000

SangCya approved in Germany

April 12, 2000

Apligraf PMA supplement tentatively scheduled for FDA review in May

April 11, 2000

New formulation of Hectorol approved by FDA

April 11, 2000

Bayer obtains first approval worldwide for new antiallergic agent

April 11, 2000

FDA gives go-ahead for Access to commence OraDisc clinical trials

April 5, 2000

Another indication for Enbrel will be discussed at advisory committee meeting

April 5, 2000

CollaGenex seeks FDA approval for new dosage form of Periostat

April 5, 2000

Avandia receives FDA approval for treatment of type II diabetes in combination with sulfonylureas

April 4, 2000

SmithKline Beecham claims 5-HT6 antagonists for ADHD

March 30, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 9, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Brenig Therapeutics discovers new LRRK2 inhibitors
BioWorld Science
Brenig Therapeutics Inc. has described leucine-rich repeat kinase 2 (LRRK2; dardarin) and (LRRK2; dardarin) (G2019S mutant) inhibitors reported to be useful for...